Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia
An investigational anti-CD38 monoclonal antibody (CM313) rapidly increased platelets in immune thrombocytopenia (ITP) patients to levels sufficient for preventing bleeding, ...
Read moreAn investigational anti-CD38 monoclonal antibody (CM313) rapidly increased platelets in immune thrombocytopenia (ITP) patients to levels sufficient for preventing bleeding, ...
Read more© 2023 earth-news.info